@aacrjournals
The American Association for Cancer Research’s 10 peer-reviewed journals provide a renowned, respected forum for publishing the most innovative cancer science, encompassing the full spectrum of basic, translational, clinical, and epidemiological research.
Attending the AACR Special Conference on RAS Oncogenesis and Therapeutics? Join Lisa Situ, PhD, Assistant Editor of Cancer Discovery, at the Networking Roundtables tomorrow morning from 7:00 AM – 8:00 AM to learn about publishing your research. #AACRras26
You've been published—now check out these tips for getting your work out there!
📰Contact your institution’s press office about news releases and media promotion
🎤Reference your article in conference presentations
📱Share and tag on social media
📈Track your article’s impact by monitoring usage
Read the science behind the art. 📖
Check out this article featured on the 2026 cover of Cancer Research Communications: Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity buff.ly/KoJ7ISc
#OpenAccess
Attending #AACRras26? Lisa Situ, PhD, Assistant Editor of Cancer Discovery, would love to hear about your research! Connect with her to discuss publishing opportunities in the AACR Journals.
Abigail Cleveland, PhD, Assistant Editor of Blood Cancer Discovery is at the Cancer Epigenetics Institute Symposium 2026 in Philadelphia.
If you have a question about the journal or are interested in discussing your research, reach out to her at abigail.cleveland@aacr.org
Read the science behind the art. 📖
Featured on the 2026 cover of Cancer Research Communications: Assessing Racial Disparities in Guideline-Concordant Care and Clinical Outcomes after Surgical Resection of Nonmetastatic Colon Cancer at a Comprehensive Cancer Center buff.ly/HgToPbf
#OpenAccess
Read about the new teams and their potential impact in this new In Focus, just published in Cancer Discovery:
The Five New Cancer Grand Challenges Teams Taking on the Biggest Questions in Cancer Research doi.org/10.1158/2159...
Abigail Cleveland, PhD, Assistant Editor of Blood Cancer Discovery is attending the Cancer Epigenetics Institute Symposium 2026 in Philadelphia on March 5.
If you have a question about the journal or are interested in discussing your research, reach out to her at abigail.cleveland@aacr.org
A Legacy of Enduring Discovery buff.ly/60tdctw
Read the editorial by Cancer Discovery Editor-in-Chief Lewis C. Cantley.
Read the science behind the art. 📖
Featured on the 2026 cover of Cancer Research Communications: First-in-Human Study of 23ME-00610, an Antagonistic Antibody for Genetically Validated CD200R1 Immune Checkpoint, in Participants with Advanced Solid Malignancies buff.ly/4kuGMHT
#OpenAccess
Abigail Cleveland, PhD, Assistant Editor of Blood Cancer Discovery is attending the Cancer Epigenetics Institute Symposium 2026 in Philadelphia on March 5.
If you have a question about the journal or are interested in discussing your research, reach out to her at abigail.cleveland@aacr.org
#GLP1-RA use may improve OS in #breastcancer survivors. Published in @aacrjournals.bsky.social journal Cancer Research Communications.
https://bit.ly/479Sg6O
#bcsm
Read the science behind the art. 📖
Read this study featured on the 2026 cover of Cancer Research Communications: Single-Cell RNA Sequencing before and after Light Chain Escape Reveals Intrapatient Multiple Myeloma Subpopulations with Divergent Osteolytic Gene Expression buff.ly/IU4ibUe
#OpenAccess
The Resource Report from Cancer Epidemiology, Biomarkers & Prevention is a means for the research community to share major population-focused data resources, including cohorts, consortia, networks, registries, and other valuable datasets.
➡️Submit your own Resource Report: buff.ly/PMee8qB
Not only do AACR Members receive a 10% discount on publishing fees, but some AACR scientific working groups offer additional discounts on top of this. Learn more: buff.ly/6qmKLPX
Read the science behind the art. 📖
Check out this article featured on the 2026 cover of Cancer Research Communications: Drug–Drug Interaction Liabilities with BTK Inhibitor TL-895 buff.ly/MnCacD3
#OpenAccess
When you submit to an AACR Journal, you'll benefit from rapid decision and publication times. Learn more about the Manuscript Turnaround Guarantee for Active AACR Members: buff.ly/RF6S0Bu
Have you read the Cancer Research Resources collection from Molecular Cancer Research? Showcasing biological and computational models and sophisticated atlases, this collection highlights exciting new technologies as drivers of discovery and hypothesis generation. Learn more: buff.ly/kHJHFAk
Read the science behind the art. 📖
Read this article featured on the 2026 cover of Cancer Research Communications: Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment–dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors buff.ly/B6MEB0o
#OpenAccess
Read the science behind the art. 📖
Check out this article featured on the 2026 cover of Cancer Research Communications: Inhibition of Extracellular Matrix Protein Fibulin-3 Reduces Immunosuppressive Signaling and Increases Macrophage Activation in Glioblastoma buff.ly/2t6FkRV
#OpenAccess
Former AACR President Elizabeth Jaffee, MD, FAACR, highlights how #AACRio26 brings together immunologists and others from across the cancer research community to accelerate progress in immuno-oncology for the benefit of patients everywhere. buff.ly/CpEPTjI #AACRFellows
Cancer vaccines are here, and research is identifying how to push T cells even further so they thrive in the tumor microenvironment. Learn more about the opening‑night #AACRIO26 keynote addresses from #AACRFellows Elizabeth Jaffee and Philip Greenberg on the #AACRBlog: buff.ly/uKglwKq
The collection, Advances in Targeted Protein Degradation: PROTACs and Molecular Glues features recent research and review articles highlighting key advances in PROTAC and molecular glue development.
Explore the research: buff.ly/xdWDulw
Read the science behind the art. 📖
Read this study featured on the 2026 cover of Cancer Research Communications: Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer buff.ly/pRkO1CN
#OpenAccess
Sign up to receive alerts directly to your inbox to keep up with the latest published issues: buff.ly/MPqGjG9
Have you picked your favorite 2025 Cancer Research cover? There’s still time to cast your vote. Vote now and help us recognize the journal’s best art of the year. Voting ends on Monday, March 16. buff.ly/aUCYymK
Read the science behind the art. 📖
Check out this article featured on the 2026 cover of Cancer Research Communications: Loss of Sorting Nexin 10 Accelerates KRAS-Induced Pancreatic Tumorigenesis buff.ly/w3LknGD
#OpenAccess
Check out the commentary: Different Diseases, Different Escapes: Trastuzumab Deruxtecan Resistance in HER2-Amplified versus HER2-Low Breast Cancer buff.ly/wIvlObw
From the February issue of Cancer Discovery: Trastuzumab Deruxtecan (T-DXd) Resistance via Loss of HER2 Expression and Binding buff.ly/LdVBL4G
Have a new drug candidate whose structure has not been previously reported in the literature? Submit your study to Molecular Cancer Therapeutics as a First Disclosure article. Learn more: buff.ly/FleTsdi
